Ultrasound Elastography Application in Cesarean Section Scar Defect

Ultrasound Elastography Application in the Assessment of Cesarean Section Scar Defect.

Cesarean Section Scar Defect(CSD) is one of the complications after cesarean section. CSD will cause many long term complications, such as abnormal uterine bleeding, infertility, uterine scar pregnancy and uterine rupture. Transvaginal ultrasound was used to detect uterine scar defects commonly. Ultrasound elastography is a modern imaging technique that has developed rapidly in recent years. Thus, this study intend to investigate the application of Ultrasound Elastography in Cesarean Section Scar Defect.

Study Overview

Status

Withdrawn

Intervention / Treatment

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200092
        • Xinhua Hospital Affiliated To Shanghai Jiaotong University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

women who were diagnosed with CSD

Description

Inclusion Criteria:

  • Clearly diagnosed with CSD
  • No serious medical problems (important viscera function in the normal range). uterine fibroids no more than 5cm
  • Sign the informed consent.

Exclusion Criteria:

  • Indefinite diagnosis.
  • Malignant tumors.
  • With severe medical problems (severe liver disease, kidney disease, respiratory diseases, heart disease or uncontrolled diabetes, epilepsy, etc., dysfunction of important organs).
  • Pregnant.
  • Mental diseases.
  • Unwilling to comply with the research plan.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Ultrasound Elastography
Patients will be examined by ultrasound elastography.
Patients will be examined by ultrasound elastography.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
thickness of the remaining muscular layer
Time Frame: 4 weeks before vaginal repair of CSD
The thickness of the remaining muscular layer is measured by ultrasound
4 weeks before vaginal repair of CSD
thickness of the remaining muscular layer
Time Frame: 12 weeks after vaginal repair of CSD
The thickness of the remaining muscular layer is measured by ultrasound
12 weeks after vaginal repair of CSD
strain ratio (SR)
Time Frame: 4 weeks before vaginal repair of CSD
the ratio of mean strain in the lesion to the adjacent background tissue
4 weeks before vaginal repair of CSD
strain ratio (SR)
Time Frame: 12 weeks after vaginal repair of CSD
the ratio of mean strain in the lesion to the adjacent background tissue
12 weeks after vaginal repair of CSD

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Wang Xipeng, Dr, Xinhua Hospital Affiliated To Shanghai Jiaotong University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2022

Primary Completion (Estimated)

June 30, 2024

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

March 19, 2022

First Submitted That Met QC Criteria

May 5, 2022

First Posted (Actual)

May 6, 2022

Study Record Updates

Last Update Posted (Actual)

April 19, 2024

Last Update Submitted That Met QC Criteria

April 17, 2024

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • XH-21-015

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Section; Dehiscence

Clinical Trials on Ultrasound Elastography

Subscribe